Luc-Matthieu Fornecker
0000-0002-1866-971X
3 papers found
Refreshing results…
Randomized Phase III Trial Evaluating Subcutaneous Rituximab for the First-Line Treatment of Low–Tumor Burden Follicular Lymphoma: Results of a LYSA Study
The landscape of copy number variations in classical Hodgkin lymphoma: a joint KU Leuven and LYSA study on cell-free DNA
Temporal multiomic modeling reveals a B-cell receptor proliferative program in chronic lymphocytic leukemia
Missing publications? Search for publications with a matching author name.